DURVALUMAB ( ASTRAZÉNECA ) AFTER CHEMORADIOTHERAPY . NEW STANDAR Of Care For Limited-Stage Small-Cell Lung Cancer , Summary By Estela Rodriguez : mPFS : 16.6 vs 9.2 Mos ( HR 0.76 ) . mOS : 56 vs 33 Mos ( HR 0.74 ) .